Psychopharmacology News and Research

RSS

Psychopharmacology is the study of drug-induced changes in mood, sensation, thinking, and behavior.

Study: Promising new treatment for children with ADHD shows improvement in efficacy

A new study in children aged 6 to 12 years of dasotraline, a promising new treatment for attention deficit hyperactivity disorder, showed significant improvement in efficacy in the treatment of ADHD compared to placebo beginning at week 1 and continuing throughout the study.

4 Feb 2019

Reassuring findings on the link between antidepressants and fertility

Based on limited research, there's no strong evidence that selective serotonin-reuptake inhibitors (SSRIs) - the most widely used class of antidepressants - have an adverse impact on fertility, according to a paper in the Harvard Review of Psychiatry.

25 Jan 2019

Improvements in pharmacological study to fight cognitive impairment in schizophrenia

A study by the UPV/EHU has assessed the effectiveness of various drugs, which are used to delay cognitive deterioration in patients with Alzheimer's, in improving cognitive impairment displayed by patients with schizophrenia.

17 Jan 2019

Study proposes improvements in pharmacological study of cognitive function enhancers in schizophrenia

Schizophrenia is a serious, chronic mental disorder involving a series of symptoms. It is one of the leading causes of disability worldwide.

16 Jan 2019

Incorrect prescribing warnings in electronic prescribing systems

Electronic prescribing is becoming widespread. All states allow it, some states require it, and many institutions now mandate electronic prescribing.

12 Dec 2018

Discovery would help specify role of genetics in the development of neuropsychiatric disorders

Neurobiologists from I.M. Sechenov First Moscow State Medical University confirmed that stress in early age affects the mice with activated and deactivated CDH13 gene in different ways.

27 Nov 2018

Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia

Nightmares and insomnia often accompany posttraumatic stress disorder and increase suicide risk.

19 Nov 2018

New reviews analyze symptom stability over the course of psychiatric disorders

In patients with psychiatric disorders, stability of symptoms has important implications for diagnosis, prognosis, and treatment.

31 Oct 2018

Study reveals connection between hunger and mood

It seems "hangry" isn't just a made-up term. University of Guelph researchers have revealed that the sudden drop in glucose we experience when we are hungry can impact our mood.

25 Sep 2018

Inhaled form of high blood pressure drug has potential to treat anxiety, pain

An inhaled form of a high blood pressure medication has potential to treat certain types of anxiety as well as pain, according to a new study by the Centre for Addiction and Mental Health.

11 Sep 2018

Cancer patient-centered video blogs yield most empathetic responses from viewers

As people with cancer use social media to find and develop support systems, a new study looks at YouTube content to determine what kinds of videos elicit an empathetic response from viewers.

5 Sep 2018

Single dose of cannabidiol showed effective results in rats with symptoms of depression

Commercial antidepressants typically take two to four weeks to have a significant effect on a depressed patient. They are also inneffective in approximately 40% of the cases.

31 Aug 2018

Ketamine may be potential therapeutic option for adolescents with treatment-resistant depression

A new study has shown a significant average decrease in the Children's Depression Rating Scale among adolescents with treatment-resistant depression who were treated with intravenous ketamine.

2 Aug 2018

Depression and anxiety in heart failure patients linked to adverse outcomes

Symptoms of depression and anxiety are present in about one-third of patients with heart failure - and these patients are at higher risk of progressive heart disease and other adverse outcomes, according to a review and update in the July/August issue of Harvard Review of Psychiatry.

6 Jul 2018

URI researchers working to develop novel medication to treat alcohol use disorder

Alcohol abuse is among the leading causes of preventable death in the United States, killing more than 88,000 people a year, according to the Centers for Disease Control.

28 Jun 2018

New study focuses on best, cost effective practices to bridge treatment gap for brain disorders

Up to eight out of ten patients with a brain disorder remain untreated or inadequately treated. But what is the best practice - and above all, most cost effective - healthcare interventions to bridge the treatment gap? This was the focus of the European Brain Council's study entitled The Value of Treatment which was discussed at the Congress of the European Academy of Neurology in Lisbon.

18 Jun 2018

Combination of physical fitness and aortic stiffness explains rate of memory decline in older people

The rate of decline in certain aspects of memory may be explained by a combination of overall physical fitness and the stiffness of the central arteries, researchers from Swinburne's Centre for Human Psychopharmacology have found.

12 Jun 2018

MDMA appears to help in treating PTSD patients

When lasting trauma is caused by callous acts of violence, the key to recovery can be making meaning out of meaninglessness.

16 May 2018

Scientific understanding of PSTD points to new treatment and prevention strategies

Recent advances in scientific understanding of how posttraumatic stress disorder develops and persists may lead to more effective treatment and even prevention of this debilitating disorder, according to the May/June special issue of Harvard Review of Psychiatry, published by Wolters Kluwer.

10 May 2018

Experts discuss how medicinal cannabis can impact opioid crisis

A multidisciplinary panel of experts discussed how medicinal cannabis can impact the opioid crisis, though clinical research to quantify this is difficult given strict federal laws

9 May 2018